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Introduction: Subjective fatigue has been recognised as an important, multi-component symp-
tom in COPD. Pulmonary Rehabilitation (PR) improves fatigue component of the Chronic Res-
piratory Questionnaire, a quality of life (QoL) measure. However, it is not clear if all fatigue
dimensions are affected equally. This study aims to evaluate changes in subjective multidi-
mensional fatigue among people with COPD who participated in PR.
Methods: Thirty seven stable COPD patients were recruited; 23 patients (15 male) mean age
68.5 (range 49e86) yrs, mean (SD) %predicted FEV1 45.3 (19.8); completed 7 weeks of PR. As-
sessments (pre and post PR) consisted of the Multidimensional Fatigue Inventory (MFI-20), QoL
(SGRQ), Anxiety and Depression (HADS), the London Chest Activity of Daily Living Scale
(LCADL), muscle strength, incremental (ISWT) and endurance (ESWT) shuttle walk tests. The
differences between pre and post PR fatigue were tested using Wilcoxon’s test and relation-
ships with other outcomes were examined using Spearman’s correlation.
Results: There were statistically significant improvements in Reduced Activity (RA)
(p Z 0.01), General (GF) (p < 0.01) and Physical Fatigue (PF) (p Z 0.03) components of
MFI-20 after PR, but there were no differences in Motivation or Mental Fatigue (p > 0.05).
There were significant improvements in ISWT (p < 0.05), ESWT (p < 0.01) and muscle strength
(pZ 0.03). Statistically significant correlations (p < 0.05) were found between changes in GF
and in both ISWT (rZ 0.43) and SGRQ impact (rZ 0.46); and between RA and ESWT changes
(r Z 0.45).habilitation Science, Faculty of Health, Social Care and Education, St. George’s University of London
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96 A. Lewko et al.Conclusions: Some dimensions of fatigue in COPD are modifiable by a 7-week PR programme.
Change in fatigue dimensions in COPD may be associated with a change in maximal or endur-
ance walking distances or QoL.
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Subjective fatigue is an important and highly prevalent
symptom in Chronic Obstructive Pulmonary Disease (COPD)
[1]. People with COPD experience greater fatigue than
healthy older people [2e4] and this, in turn, is associated
with the severity of the disease rather than age itself.
COPD-related fatigue (COPD-RF) affects patients’ func-
tional performance [5,6], quality of life (QoL) [2,7] and may
be an important barrier to undertaking physical activity
[8,9]. Fatigue, in COPD is a complex symptom, and as such a
multidimensional approach is required to its assessment.
The findings from regression studies revealed that dysp-
noea, depression, muscle weakness, decreased exercise
capacity, airway limitation, body weight and exercise de-
saturation were indicators in the perception of COPD-RF
[2,3,5,10]. Therefore, these factors should be considered
when planning a comprehensive treatment of COPD-RF.
Pulmonary rehabilitation (PR) is a well established gold
standard of care for COPD patients, which improves patients’
dyspnoea, QoL and exercise tolerance [11,12]. Recent studies
have also shown that cognitive function [13], depression and
anxiety [14,15] may improve with PR. One meta-analysis
demonstrated significant improvement in the fatigue sub-
scale of a QoL questionnaire after PR [16]. However, there is
little attention to this outcome in rehabilitation literature and
only a few studies considered fatigue as a symptom-specific
assessment [17,18]. Although some studies indicate that PR
may somewhatmodify fatigue in COPD [16,17], it is not clear if
the separate general; physical; and psychological aspects of
fatigue may be improved equally following PR. Exercise
training is an important component of PR leading to im-
provements in muscle strength and exercise tolerance
[19e21], which in turn may influence physical components of
COPD-RF. However, rehabilitation also aims to address psy-
chological aspects of COPD using and education and behav-
ioural approaches [22e25], these in turn may modify the
motivational and cognitive aspects of fatigue. This study,
therefore, aims to evaluate whether COPD-RF dimensions,
assessed with the MFI-20, change after a seven-week PR pro-
gramme and if the changes in fatigue dimensions are associ-
ated with changes in other established outcome measures.
Methods
Full ethical consent was obtained from the Royal Marsden
Local Research Ethics Committee (London, UK). All patients
gave written informed consent prior to entering the study.
Subject recruitment
Thirty seven stable COPD subjects (defined as FEV1/FVC
ratio <0.7) were recruited from those on the waiting listfor PR at St. George’s Hospital, London (UK) until reaching
a desired sample size (see statistical analysis). An invita-
tion letter was sent with a return opt-out slip and those
who agreed were contacted by phone. Diagnosis of COPD
had been previously confirmed by a general practitioner or
a chest physician and medication was optimised. Patients
were excluded if they had unstable angina, significant
co-morbidities, such as rheumatoid arthritis, stroke,
carcinoma, psychiatric personality disorders, intermittent
claudication or other mobility limiting conditions. Patients
with other mild, stable and well controlled co-morbities
were included e.g. osteoarthritis, hypertension or diet-
controlled diabetes.
Assessments
Patients included in the study attended the hospital for an
individual baseline assessment. Assessment was carried out
over two days if necessary, for instance, when the patient
was too tired to continue. After attendance of 14 rehabil-
itation sessions over at least seven and maximum of 10
weeks, the patients were reassessed at the separate follow
up session within one week from the last PR session. Those
who were unable to complete 14 sessions were classified as
dropped-out. Measurements taken included height (cm),
weight (kg) and body composition, assessed using a non-
invasive bioelectrical impedance technique (Body compo-
sition analyser, Tanita Ltd BC-418MA, UK). Baseline Forced
Expiratory Volume in one second (FEV1) and Forced Vital
Capacity (FVC) were assessed using spirometer Micro Plus
MS03 (Micro Medical Ltd, Rochester UK) according to ERS/
ATS recommendations [26].
Subjective fatigue was assessed using the Multidimen-
sional Fatigue Inventory (MFI-20), a 20-item self-report in-
strument designed to measure subjective fatigue [27,28].
The questionnaire asks patients to describe how they have
been feeling lately. For issues of clarity this was specified as
“within the last two weeks”. The tool consists of five di-
mensions covering General Fatigue (GF), Physical Fatigue
(PF), Reduced Activity (RA), Reduced Motivation (RM) and
Mental Fatigue (MF). Each dimension has 4 items, each item
scored from 1 to 5 with higher scores representing greater
levels of fatigue.
Mood status: All participants completed the Hospital
Anxiety and Depression Scale (HADS). The HADS is a ques-
tionnaire designed to measure depressive and anxiety
moods separately [29]. A score of 11 or higher for either of
the components indicates probable presence of a mood
disorder.
Baseline breathlessness level was assessed using the
Medical Research Council Dyspnoea Grade (MRC) [30].
Breathlessness during Daily Activities was assessed using
the London Chest Activity of Daily Living Scale (LCADL) [31].
The questionnaire consists of 15 daily activities, with each
Table 1 Comparison of patients who completed PR with
those who dropped out.
Completers
n Z 23
Dropped out
n Z 14
p-value
Age
mean (SD)
68.5 (8.7) 71.7 (6.8) ns
%predicted FEV1
mean (SD)
45.3 (19.8) 42.3 (15.5) ns
HADS e median (IQR)
Depression 4 (4) 7(5) p Z 0.03
Anxiety 5 (3) 8(4.5) p Z 0.03
SGRQ e median (IQR)
Symptoms 63.0 (19.7) 74.4 (18.5) ns
Activity 72.3 (19.6) 85.5 (37.4) ns
Impact 30.8 (16.1) 44.5 (28.5) p Z 0.01
Total 45.8 (21.0) 61 (23.2) p Z 0.02
MFI-20 e median (IQR)
General Fatigue 12 (5) 14.5 (2.5) ns
Physical Fatigue 15 (5) 14 (8) ns
Reduced Activity 13 (7) 12.5 (7.5) ns
Reduced
Motivation
9 (6) 9 (8.7) ns
Mental Fatigue 8 (7) 9.5 (6.5) ns
Independent t-test for age and %predicted FEV1 differences or
ManneWhitney tests for other variables.
ns e not significant difference (p > 0.05); FEV1 e Forced
Expiratory Volume in first second; HADS e hospital anxiety
and depression scale, SGRQ e Saint George’s Respiratory
Questionnaire, MFI 20 e Multidimensional Fatigue Inventory.
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calculated, with the higher score indicating more breath-
lessness during daily activities.
Health related QoL was assessed using Saint George’s
Respiratory Questionnaire (SGRQ) [32].
Maximal exercise tolerance was assessed using the In-
cremental Shuttle Walking Test (ISWT), an incremental,
externally paced exercise capacity test conducted accord-
ing to standardised procedure [33]. Endurance exercise
tolerance was then assessed at 85% of peak oxygen uptake
(VO2), estimated from ISWT, using the Endurance Shuttle
Walking Test (ESWT) [34]. Prior to and after each test
percutaneous arterial oxygen saturation (SpO2) and heart
rate were measured using a pulse oxymeter (Pulsox-3i-
Konika Minolta, Singapore) applied to the finger. Borg CR 10
(Breathlessness) and Borg Rating of Perceived Exertion
(RPE) scales were scored at the end of each test [35,36].
Quadriceps maximal torque was measured using a
“Cybex Norm Testing and Rehabilitation System”.
Concentric knee extensions and flexions were performed
and maximally at an angular velocity of 60/sec. Maximum
torque was recorded during isokinetic work of the 10-
reperition as the best attempt of the dominant side.
Pulmonary Rehabilitation programme
Subjects underwent a seven week outpatient PR pro-
gramme with two supervised sessions per week, based in
St. George’s Hospital, London, UK. Hence, the completed
programme consisted of 14 sessions. As this was a “rolling”
programme, patients who missed a session(s) could
continue beyond 7 weeks until they attended 14 supervised
sessions for maximum of 10 weeks. Each session consisted
of 1 h exercise training and 30 min of education. The ex-
ercise training was designed as circuit training and con-
sisted of an individually tailored programme of aerobic
endurance or interval, and upper and lower limbs resis-
tance training. Endurance or interval training were used to
achieve exercise intensity of 60e80% VO2 peak based on
ISWT estimation. The higher intensity was promoted and
gradual progression was encouraged each week. Each
training session consisted of aerobic training which
included cycling, treadmill walking and step climbing. Pa-
tients were also encouraged to exercise at home between
hospital sessions according to an exercise diary given by
the therapist. Education sessions were delivered by a
multidisciplinary team and covered pathophysiology, ben-
efits of exercise, self management, breathing control,
sputum clearance, medication and oxygen, inhaler tech-
niques, nutrition and diet, relaxation and smoking cessa-
tion. Patients were also taught strategies to cope with
breathlessness, breathing control and energy conservation
techniques.
Statistical analysis
Sample size calculation had been performed prior the study
based on mean GF (SD) sub-score of MFI-20 (13.9 (4.2)) from
a previous study by Breslin et al. [7]. Assuming change of
3.5 points in MFI-20, the study required minimum 22 pa-
tients at power 80% and p < 0.05. Data from patients whocompleted 14 PR sessions or dropped out were collected
and analysed. Mean and standard deviation (SD) for para-
metric, and median and inter-quartile range (IQR) for non-
parametric variables were recorded. Differences in base-
line measurements between the rehabilitation drop-out
and completed groups were examined using independent
samples parametric or non-parametric tests, as appro-
priate. Wilcoxon signed-rank tests were performed on the
completed PR group to test for differences in pre and post
PR results. Spearman’s rank correlation was used to identify
associations between the changes in fatigue dimensions
after PR and other changes in PR outcomes. In all tests a p-
value <0.05 was taken to indicate a statistically significant
result. All statistical analysis was carried out in SPSS 15.0.
Results
Thirty seven COPD subjects entered the rehabilitation
programme; of these, 23 patients (15 male) completed the
programme and were reassessed. Those who completed PR
had a mean age of 68.5 years (range 49e86), their mean
(SD) %predicted FEV1 was 45.3 (19.8) and FEV1/FVC ratio
0.44 (0.12). Comparison between this group of patients and
those who dropped out from the rehabilitation programme
at baseline showed no significant differences in initial fa-
tigue level, age or airway obstruction severity. However,
those who dropped out had significantly higher scores for
both HADS depression (p Z 0.03) and anxiety (p Z 0.03);
98 A. Lewko et al.and for SGRQ impact (p Z 0.01) and total (p Z 0.02). See
Table 1 for details.Evaluation of changes in fatigue dimension scores
after PR
Most of the 23 patients who completed the rehabilitation
programme showed improvements in fatigue score but im-
provements were not equally distributed across the 5
components of fatigue. A reduction in fatigue was observed
in 16 patients for GF and PF scores, 14 for RA, 11 for RM and
9 for MF. See Fig. 1 for the individuals’ fatigue dimension
scores before and after PR.
Median scores for all dimensions except PF vary little pre
and post PR. Median scores post PR programme were sta-
tistically significantly lower for RA, GF and PF, but not for
RM or MF. As can be seen in Fig. 2 the IQR change little pre
and post PR for GF, PF and RA. However, the IQR is reduced
post PR for RM and MF, indicating smaller differences in theC. D
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Figure 1 Individuals’ cases MFI-20 score pre and post PR for A.
Reduced Motivation, E. Mental Fatigue.scores for the middle 50%. The comparison of median fa-
tigue score before and after rehabilitation showed signifi-
cant differences only in selected dimensions (see Table 2).Evaluation of changes in PR outcomes and their
association with changes in fatigue scores
Most patients improved their maximal and endurance
walking distance. 17 out of 23 improved on ISWT and 14 out
of 20 on their ESWT. At baseline, 11 of the 23 patients
showed de-saturation during exercise, defined as a fall of
4% to below 90%, but during reassessment post PR satura-
tion fell in only 8 patients. Although not significant,
there was a trend towards improvement in exercise de-
saturation.
There were significant differences in ESWT, ISWT, SGRQ
activity scores and mmTq between the start and the end of
the PR programme. However, no significant differences
were observed in BMI, total SGRQ, LCADL measures or HADS.
A-C p<0.05
Change in Reduced Motivation
 pre PR post PR
0
5
10
15
20
M
F
I
 
2
0
 
s
c
o
r
e
.
Change in Physical Fatigue
pre PR post PR
0
5
10
15
20
25
M
F
I
 
2
0
 
s
c
o
r
e
General Fatigue, B. Physical Fatigue, C. Reduced Activity, D.
Figure 2 MFI-20 scores pre and post PR. *Wilcoxon’s ranks tests: General Fatigue (p < 0.01), Physical Fatigue (0.03), Reduced
General Fatigue, Physical Fatigue, Reduced Activity, Reduced Motivation and Mental Fatigue; *p < 0.05 (Wilcoxon’s ranks tests).
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outcome measures are presented in Table 3.
Relationships between the change in fatigue dimensions
following PR and change in the other measurements, as
presented in Table 3, were assessed. There were moderate
correlations between the change in GF and the change in
ISWT (r Z 0.43) and SGRQ impact (r Z 0.46), and for RA
and the change in ESWT (r Z 0.45). No other significant
relationships were found.
Discussion
This study shows that subjective fatigue is modified
following a modest seven week rehabilitation programmeTable 2 Fatigue before and after PR for COPD patients
completing PR programme.
Pre PR
median
(IQR)
Post PR
median
(IQR)
p-value
Wilcoxon’s
tests
MFI 20 General
Fatigue
12 (5) 11 (5) <0.01
MFI 20 Physical
Fatigue
15 (5) 12 (4) 0.03
MFI 20 Reduced
Activity
13 (7) 11 (5) 0.01
MFI 20 Reduced
Motivation
9 (6) 9 (3) ns
MFI 20 Mental
Fatigue
8 (7) 8 (4) ns
ns e not significant difference (p > 0.05); MFI 20 e Multidi-
mensional Fatigue Inventory.and the improvement is evident in three out of five
dimensions of MFI-20. Previous studies demonstrated
improvement in fatigue component health related QoL
after PR as shown by a meta-analysis [16]. Although in a
recent RCT [18] of 26 patients no improvement was
demonstrated with regard to fatigue frequency, duration,
severity or functional limitations following PR, the study
was underpowered and the results may be subject to error.
The selection of the tool the Fatigue Impact Scale and its
responsiveness may also explain the lack of detected
improvement. However, other data presented by Peters
et al. [17] a year earlier, implied that unidimentional fa-
tigue, assessed using the Checklist Individual Strength, may
be significantly reduced after PR.
Our findings show that there are significant improve-
ments in the Reduced Activity, General and Physical Fa-
tigue components of MFI-20 but not in Reduced Motivation
or Mental Fatigue. This study is the first to report changes in
individual dimensions of fatigue following PR among pa-
tients with COPD. Although PR is a holistic programme,
which is intended to address all areas of patients’ health,
the improvement was demonstrated only in selected fa-
tigue dimensions. There may be various explanations for
this finding; our sample size calculation was based on the
General Fatigue subscale, which might have not been
adequately powered to detect changes in all dimensions.
Moreover, the relatively short 7-week programme may be
long enough to form changes in general and physical di-
mensions, but may be insufficient to modify the motiva-
tional or mental fatigue. Furthermore, during rehabilitation
programme no ambulatory oxygen was used in order to
normalise exercise hypoxaemia unless patient was using
Long Term Oxygen Therapy or had SpO2 below 85% on ex-
ercise. In this cohort, none of the patients met these
criteria therefore no oxygen was offered. An earlier study
Table 3 Outcome measures before and after PR for COPD
patients completing PR programme (n Z 23).
Pre PR Post PR p-value
Wilcoxon’s
tests
Depression (HADS)
median (IQR)
4 (4) 4 (4) ns
Anxiety (HADS)
median (IQR)
5 (3) 5 (5) ns
SGRQ median (IQR)
Symptoms 63.0 (19.7) 66.3 (22.6) ns
Activity 72.3 (19.6) 60.3 (25.2) <0.01
Impact 30.8 (16.1) 24.8 (25.5) ns
Total 45.8 (21.0) 41.0 (19.3) ns
BMI
mean (SD)
25.7 (3.7) 26.0 (3.4) ns
LCADL
median (IQR)
24 (10) 23 (10) ns
ISWT
mean (SD)
348.3 (196.8) 381.7 (196.8) <0.05
ESWT
mean (SD)
357.7 (332.8) 488.6 (424.0) <0.01
SpO2 drop
mean (SD)
6.7 (5.6) 5.3 (4.7) ns
mm Tq
mean (SD)
57.6(21.3) 62.0(16.8) 0.03
ns e not significant difference (p > 0.05); HADS depression e
depression score of hospital anxiety and depression scale, HADS
anxiety e anxiety score of hospital anxiety and depression
scale, SGRQ e Saint George’s Respiratory Questionnaire, LCADL
e London Chest Activity of Daily Living scale, BMI e Body Mass
Index, ISWT e Incremental and ESWT e Endurance Shuttle Walk
Tests, SpO2 drop e change in percutaneous oxygen saturation,
mm Tq e quadriceps muscle torque.
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ercise de-saturation and motivational, general and mental
fatigue [3]. It is possible that, improvement in exercise
oxygenation could have led to greater changes in motiva-
tional and mental fatigue. However, as ambulatory oxygen
was not used to correct exercise de-saturation in this study
this theory remains untested. Surprisingly, there was a
trend toward an improvement in exercise oxygenation at
the end of PR, which may be due to physiological adapta-
tion following physical training or simply a pulsoxymetric
variability [37]. Previous reports in this area are inconsis-
tent [38,39].
Furthermore, an essential component of all PR is phys-
ical exercise training and this study showed, as expected,
good improvements in exercise tolerance and muscle
strength, but not in psychological outcomes such as anxiety
or depression. Depression has been shown to be an impor-
tant predictor of COPD-RF [2,3] and the lack of individual
cognitive therapy sessions or depression management in
this programme may explain insignificant change in moti-
vational and mental fatigue. However, anxiety and
depression in this cohort of patients were mostly within
normal values with patients with higher scores more likely
to drop out as reflected in recent findings by Hogg et al.[40]. As reported by Harrison and co-workers no improve-
ment in mood should be expected in patients with baseline
low scores [41]. Similarly, the scores for motivational and
mental fatigue were lower than for the 3 other dimensions,
which may indicate mostly normal fatigue values for this
cohort. Consequently, the scores for these two dimensions
following PR were less likely to improve significantly.
Future well powered studies are needed to investigate
changes in these psychological dimensions. Furthermore,
those patients with higher level of fatigue may show poor
uptake and adherence with rehabilitation as shown by Hogg
at al [40]. and assessment of fatigue may help in identifying
this group of patients.
Analysis of relationships between changes in fatigue and
other outcome measures of PR revealed that the increase
in maximal exercise tolerance and prolonged endurance
walk was associated with the general and activity fatigue
dimensions. Previously, studies of fatigue in COPD have
shown that general and physical components of fatigue
may be predicted by exercise tolerance and muscle
strength [3,7,42]. These results lead to the hypothesis that
certain dimensions of COPD-RF may be modified by
increasing exercise capacity and endurance. In a recent
randomised study of PR, effect of fatigue level on outcome
measures was investigated in patients with higher and
lower baseline fatigue. Although both groups improved
their walking distance following PR [43], the improvements
in distance walked or endurance time achieved at the end
of PR were not maintained after 1-year in the high fatigue
group. Also, recent conference data from two authors
showed that lack of energy and tiredness are main barriers
for physical activity [8,9]. These suggest that higher fa-
tigue may not impact immediate outcomes of PR but it may
affect them in a long term. Therefore, subjective fatigue
may be one of the important factors considered in the
rehabilitation process. Although change in other variables
in our study, such as, muscle torque or de-saturation did
not relate to changes in fatigue, their role in fatigue
improvement cannot be excluded [42,44]. Moreover, there
were no changes to BMI following PR, which is in agreement
with one other study [45].
Due to limitations in the study design it is not possible to
say unequivocally that the changes we observed in fatigue
after pulmonary rehabilitation were solely brought about as
a result of the rehabilitation. However, previous data from
RCTs have indicated a positive effect of rehabilitation on
fatigue score [16]. This study was designed, primarily, to
test the response of MFI-20 to rehabilitation and to
compare the magnitude of change across the dimensions of
fatigue. Although this study has been conducted on a
relatively small sample of 23 patients, changes in some of
the fatigue dimensions have been identified. However, the
size of this study does not allow exploration of other fac-
tors, such as, drop out reasons or ratio. Fatigue is associ-
ated with exacerbation rate [2] which may strongly
influence attendance or a drop-out of rehabilitation
[40,46]. Although we found no difference in fatigue levels
between those who dropped out of the rehabilitation and
those who completed, this evaluation was not powered to
look at predictors of the drop-out and fatigue may well be
an important cofounder or aspect of the drop-out. This may
be a scope for future larger studies.
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The findings from this study suggest that at least three
components of MFI-20 are modified after 7-week PR. The
changes in reduced activity, general and physical fatigue,
as might be expected, were associated with improvements
in QoL, maximal or endurance walking distance. However,
it is still unclear whether motivational or mental compo-
nents of fatigue are modified by PR or whether other
problem focused modalities are required to achieve
improvement in all dimensions of COPD-RF. The multidi-
mensional nature of fatigue requires a holistic approach to
treatment which involves physical, nutritional and psycho-
logical interventions and it should be taken into consider-
ation when planning individualised patient’s care.Conflict of interest
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